China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...

Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

Adjuvant nivolumab offered sustained survival benefits in resected esophageal/GEJ cancer post chemoradiation, with PD-L1 ...

A test image that analyzed the characteristics of early Barrett neoplasms. The left side is an endoscopy picture of actual ...

Malawi holds the highest reported global age-standardized rate for esophageal squamous cell carcinoma (ESCC) incidence and ...

Foundation Medicine today announced that it has expanded its immunohistochemistry (IHC) test offerings to include MET IHC testing.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at the 2025 American Society of Clinical ...

Esophageal cancer is a malignant tumor that develops in the tissues lining the esophagus—the muscular tube that connects the throat to the stomach and helps move food for digestion. There are two ...

"Patients with metastatic esophageal squamous cell carcinoma continue to experience poor outcomes despite currently available treatments," said Mark Rutstein, MD, Head, Therapeutic Area Oncology ...

versus investigator’s choice of chemotherapy in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) with disease progression following treatment with a platinum ...

Sun Yat-sen University Cancer Center, Guangzhou 510060, China bGuangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou 510060, China cDepartment of Thoracic Oncology, ...